News In Brief: Cheap American Drugs Replaced; EMA, FDA Differ on Toansa; Apotex Warned; Cheaper Drug Recalls

“Cheap China drugs” paradigm turned on its head; EMA disagrees with FDA on Ranbaxy site; Apotex API site fails FDA test; Drug tracing will mean cheaper recalls.